$30.81
1.183.98%
Last update: Nov 9, 6:15 PM

The average analyst price target for Zymeworks is $39.62, 27.8% above the current price. Of 13 analysts, 13 rate it Buy. Targets range from $14 to $58. The latest change came on Oct 28, 2026, when Truist Securities raised its price target on Zymeworks from $34 to $35 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months